Interpreting scores on multiple sclerosis-specific patient reported outcome measures (the PRIMUS and U-FIS) |
| |
Authors: | James Twiss Lynda C Doward Stephen P McKenna Benjamin Eckert |
| |
Affiliation: | 1.Galen Research Ltd,Manchester,UK;2.Global Health Economics and Outcomes Research,Novartis Pharmaceuticals,Basel,Switzerland |
| |
Abstract: |
Background The PRIMUS is a Multiple Sclerosis (MS)-specific suite of outcome measures including assessments of QoL (PRIMUS QoL, scored 0-22) and activity limitations (PRIMUS Activities, scored 0-30). The U-FIS is a measure of fatigue impact (scored 0-66). These measures have been fully validated previously using an MS sample with mixed diagnoses. The aim of the present study was to validate the measures further in a specifically Relapse Remitting MS (RRMS) sample and to provide preliminary evidence of the responder definitions (RD; also known as minimal important difference) for these instruments. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|